Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.

Exclusion Criteria

• •Pregnant or lactating women. (Pre-menopause women, capable of bearing children will undergo pregnancy test)
• •General contraindications of infusion therapy; acute pulmonary oedema,hyperhydration and decompensated cardiac insufficiency
• •Known hypersensitivity to egg- or soy protein or any of the ingredients
• •Severe blood coagulation disorders
• •Shock necessitating acute resuscitation at the discretion of the investigator
• •Diabetes mellitus with known ketoacidosis within 7 days of onset of study treatment
• •APACHE II score \> 25
• •Renal insufficiency defined as serum creatinine value of \>1.4 mg/dl
• •Subjects with severe liver dysfunction which contraindicates the use of parenteral nutrition at the discretion of the investigator
• •Known type IV hyperlipidemia, disturbances in lipid metabolism or hypertriglyceridemia (at the time of inclusion, a blood sample (fasting) for serum triglyceride assessment has to be taken. The sample has to be analysed before start of trial treatment. In case of fasting serum triglyceride value of \>4 mmol/l (\>354 mg/dl) the subject must be withdrawn.
• •Unconscious or uncooperative patients
• •Participation in a clinical study with an investigational drug or an investigational medical device within one month prior to start of study